Literature DB >> 24854606

Efficient access to 2,3-diarylimidazo[1,2-a]pyridines via a one-pot, ligand-free, palladium-catalyzed three-component reaction under microwave irradiation.

Yuanxiang Wang1, Brendan Frett, Hong-yu Li.   

Abstract

An expeditious one-pot, ligand-free, Pd(OAc)2-catalyzed, three-component reaction for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines was developed under microwave irradiation. With the high availability of commercial reagents and great efficiency in expanding molecule diversity, this methodology is superior to the existing procedures for the synthesis of 2,3-diarylimidazo[1,2-a]pyridines analogues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24854606      PMCID: PMC4059256          DOI: 10.1021/ol501136e

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


Imidazo[1,2-a]pyridines are extremely popular among chemists and medicinal chemists due to their remarkable biological and pharmacological activities[1] such as anticancer,[2] anti-inflammatory,[3] antibacterial,[4] antiprotozonal,[5] antiviral,[6] antiulcer,[7] and antifungal.[8] Within the imidazo[1,2-a]pyridine family, several products have progressed to market, including alpidem (anxiolytic),[9] necopidem (anxiolytic),[10] saripidem (anxiolytic),[11] zolpidem (insomnia),[12] olprinone (cardiotonic),[13] minodronic acid (bisphosphonate),[14] divalpon (anxiolytic),[15] and zolimidine (antiulcer).[16] The imidazo[1,2-a]pyridine derivatives, 2,3-diarylimidazo[1,2-a]pyridines also exhibit a wide range of biological activities.[17] In particular, medicinal chemists have focused on the core structure to produce inhibitors[18] for PI3K, p38, and TGF-β kinases. Owing to the attractive biological properties of 2,3-diarylimidazo[1,2-a]pyridines, a variety of strategies to synthesize the core structure have been developed, focusing on (1) condensation between 2-aminopyridines and 2-bromo-1,2-diarylethanone;[19] (2) Suzuki-type cross-coupling between 3-halo-2-arylimidazo[1,2-a]pyridines and arylboronic acid,[20] and (3) copper-catalyzed conversion of pyridine to 2,3-diarylimidazo[1,2-a]pyridines.[21] Very recently, Pd-, Rh-, and Cu- catalyzed direct C–H arylations of 2-arylimidazo[1,2-a]pyridines at C-3 have been extensively studied (Scheme 1a).[22] The transformation is completed in stepwise sequences to afford 2,3-diarylimidazo[1,2-a]pyridines. Therefore, an efficient synthetic methodology involving commercially available and inexpensive starting materials is required to expeditiously synthesize diverse 2,3-diarylimidazo[1,2-a]pyridines. In order to develop a convenient synthetic route in conjunction with the possibility for rapid library diversification, we were interested in conducting the two-step cyclization/C–H arylation in one pot (Scheme 1b). To the best of our knowledge, there has never been a report of a one-pot, ligand-free, palladium-catalyzed, three-component reaction to afford 2,3-diarylimidazo[1,2-a]pyridines under microwave irradiation.
Scheme 1

Methods for the Synthesis of 2,3-Diarylimidazo[1,2-a]pyridines

2-Aminopyridine (1a), 2-bromo-1-phenylethanone (2a), and 1-bromo-4-nitrobenzene (3a) were chosen as model substrates to optimize the reaction conditions. We initiated our studies by examining the influence of microwave irradiation on the conversion using KOAc as the base and 10 mol % of Pd(OAc)2 as the catalyst. First, we carried out a reaction in DMF at 100 °C under microwave irradiation for 30 min, but only trace amounts of product 4aaa were detected (19% yield, Table 1, entry 1). Increasing the temperature from 100 to 120 °C improved the yield to 36% (entry 2). A high yield of 66% was obtained with a temperature of 160 °C (entry 4). Unfortunately, yields decreased with higher temperatures (entries 5 and 6). The yield was optimized to 84% by increasing the reaction time to 1 h (entry 7). Then, the reaction was performed using different catalyst loads (entry 8–11). In the presence of 8 mol % of Pd(OAc)2, a yield of 78% was obtained and a significant yield was lost with lower catalytic loads.
Table 1

Optimization of Reaction Conditionsa

entryPd(OAc)2 (mol %)basesolventtemp (°C), timeyieldb (%)
110KOAcDMF100, 30 min19
210KOAcDMF120, 30 min36
310KOAcDMF140, 30 min42
410KOAcDMF160, 30 min66
510KOAcDMF170, 30 min51
610KOAcDMF180, 30 min49
710KOAcDMF160, 1 h84
82KOAcDMF160, 1 h45
94KOAcDMF160, 1 h56
106KOAcDMF160, 1 h68
118KOAcDMF160, 1 h78
1210CsOAcDMF160, 1 h67
1310NaOAcDMF160, 1 h54
1410K2CO3DMF160, 1 h35
1510Cs2CO3DMF160, 1 h23
1610KOAcDMAc160, 1 h77
1710KOAcNMP160, 1 h62
1810KOAcxylene160, 1 h35
1910KOAcdioxane160, 1 h24
2010KOAcbutan-1-ol160, 1 h11

Reaction conditions: 1a (1 mmol), 2a (1 mmol), 3a (2 mmol), base (2 mmol), solvent (6 mL).

Isolated yield.

Reaction conditions: 1a (1 mmol), 2a (1 mmol), 3a (2 mmol), base (2 mmol), solvent (6 mL). Isolated yield. A variety of bases were investigated, such as KOAc, CsOAc, NaOAc, K2CO3, and Cs2CO3. KOAc was identified as the best base (Table 1). Finally, our study focused on testing various solvents, such as DMF, DMAc, NMP, xylene, dioxane, and 1-butanol, and among them, DMF was found to be superior (Table 1).

Scope of Phenyl Bromides,

Reaction conditions: 1a (1 mmol), 2a (1 mmol), 3 (2 mmol), Pd(OAc)2 (10 mol %), KOAc (2 mmol), DMF (6 mL), microwave, 160 °C, 1 h. Isolated yield. Reaction time is 2 h. With the optimized reaction conditions in hand, we evaluated the scope and limitations of the transformation. We initially assessed the reactions of various aryl bromides with 1a and 2a (Scheme 2). First, a series of para- or meta-substituted electron-deficient aryl bromides were examined under the optimized conditions, and the corresponding products (4aaa–d) were produced in good to excellent yields. Subsequently, disubstituted aryl bromides were subjected to the reaction and transformation occurred smoothly. The one-pot three component reaction also worked well with bromopyridine or bromopyrimidine, leading to the products (4aag–i) in good yields. Bromobenzene was also successfully employed in the reaction to produce 4aaj in 72% yield. It should be noted that electron-rich aryl bromides gave slightly lower yields than electron-deficient systems, affording the corresponding 4aak–m in 56–60% yields. Biphenyl bromide and 4-bromoisoquinoline were also found to be suitable partners, giving 4aan and 4aao in yields of 66% and 68%, respectively.
Scheme 2

Scope of Phenyl Bromides,

Reaction conditions: 1a (1 mmol), 2a (1 mmol), 3 (2 mmol), Pd(OAc)2 (10 mol %), KOAc (2 mmol), DMF (6 mL), microwave, 160 °C, 1 h.

Isolated yield.

Reaction time is 2 h.

Scope of Aminopyridines and 2-Bromophenylethanones,

Reaction conditions: 1a (1 mmol), 2a (1 mmol), 3 (2 mmol), Pd(OAc)2 (10 mol %), KOAc (2 mmol), DMF (6 mL), microwave, 160 °C, 1 h; Isolated yield. To further examine the efficiency of this one-pot reaction and to rapidly expand our unique compound collection, we extended the reaction scope to other 2-aminopyridines and 2-(bromophenyl)ethanones. As shown in Scheme 3, we were pleased to find that methyl substituted 2-aminopyridines could be smoothly transformed into the desired products (4baa and 4caa in 83% and 78% yield, respectively). The electron-withdrawing (−CN) substituent was well tolerated (4daa). To our delight, when 2-bromo-1-(4-fluorophenyl)ethanone, 4-(bromoacetyl)pyridine, and 2-(bromoacetyl)pyridine were subjected to the reaction, the corresponding products (4bba–bda) could be isolated in good to excellent yields (Scheme 3).
Scheme 3

Scope of Aminopyridines and 2-Bromophenylethanones,

Reaction conditions: 1a (1 mmol), 2a (1 mmol), 3 (2 mmol), Pd(OAc)2 (10 mol %), KOAc (2 mmol), DMF (6 mL), microwave, 160 °C, 1 h;

Isolated yield.

The reaction is not limited to synthesis of 2,3-diarylimidazo[1,2-a]pyridines. Under the same reaction conditions, 2-chloroacetaldehyde was successfully coupled with 1a and 3a to afford 2-arylimidazo[1,2-a]pyridine 6 in 65% yield (Scheme 4).
Scheme 4

Synthesis of 3-(4-Nitrophenyl)imidazo[1,2-a]pyridine via the One-Pot Procedure

We also prepared compounds 4bca and 4bdh in yields of 77% and 75%, which have been found to be active on the TGFβ-R1 kinase through a high-throughput computational screen (Figure 1).[23] Interestingly, both compounds are predicted to bind the kinase in a similar fashion to known TGFβ-R1 inhibitors (Figure 1)[24] and have calculated properties with druglike space (Table 2).
Figure 1

Computational modeling of 4bca (A) and 4bdh (B) in the TGFβ-R1 kinase (PDB: 3FAA(24)). In both cases, a pyridine moiety hydrogen bonds to the hinge with H283. 4bca creates a contact with the conserved lysine, L232. Both compounds access a lipophilic pocket to the left of L232. The hinge is shown in green, the DFG motif is shown in purple, and the C-Helix is shown in orange. Ligand/receptor interactions are denoted with black dotted lines.

Table 2

TGFβ-R1 Computational Affinity and Drug Properties

compdΔGa (kcal/mol)Kdb (nM)CLogPctPSAc2)MW (g/mol)
4bca–10.423.33.879.8330
4bdh–9.2177.32.840.3286

Calculated with Autodock Vina.

Calculated from ΔG using Kd = e–Δ at 298 K.

Calculated with ChemDraw.

Computational modeling of 4bca (A) and 4bdh (B) in the TGFβ-R1 kinase (PDB: 3FAA(24)). In both cases, a pyridine moiety hydrogen bonds to the hinge with H283. 4bca creates a contact with the conserved lysine, L232. Both compounds access a lipophilic pocket to the left of L232. The hinge is shown in green, the DFG motif is shown in purple, and the C-Helix is shown in orange. Ligand/receptor interactions are denoted with black dotted lines. Calculated with Autodock Vina. Calculated from ΔG using Kd = e–Δ at 298 K. Calculated with ChemDraw. In summary, we have developed an expeditious one-pot procedure to access 2,3-diarylimidazo[1,2-a]pyridines via a ligand-free, palladium-catalyzed, microwave-assisted three-component reaction. In addition, the availability of reagents and ease in expanding molecule diversity make the developed methodology operationally proficient and can facilitate rapid library construction. Further efforts to therapeutically evaluate the synthesized compounds are underway and will be reported in due course.
  35 in total

1.  3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.

Authors:  Robert R Singhaus; Ronald C Bernotas; Robert Steffan; Edward Matelan; Elaine Quinet; Ponnal Nambi; Irene Feingold; Christine Huselton; Anna Wilhelmsson; Annika Goos-Nilsson; Jay Wrobel
Journal:  Bioorg Med Chem Lett       Date:  2009-11-23       Impact factor: 2.823

2.  Behavioural effects of novel benzodiazepine (omega) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue.

Authors:  D.J. Sanger
Journal:  Behav Pharmacol       Date:  1995-03       Impact factor: 2.293

3.  Copper-catalyzed aerobic oxidative C-H functionalization of substituted pyridines: synthesis of imidazopyridine derivatives.

Authors:  Jipan Yu; Yunhe Jin; Hao Zhang; Xiaobo Yang; Hua Fu
Journal:  Chemistry       Date:  2013-10-21       Impact factor: 5.236

4.  The position of imidazopyridine and metabolic activation are pivotal factors in the antimutagenic activity of novel imidazo[1,2-a]pyridine derivatives.

Authors:  Wael M El-Sayed; Warda A Hussin; Yasair S Al-Faiyz; Mohamed A Ismail
Journal:  Eur J Pharmacol       Date:  2013-06-06       Impact factor: 4.432

5.  Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis.

Authors:  Okseon Kim; Yujeong Jeong; Hyunseung Lee; Sun-Sun Hong; Sungwoo Hong
Journal:  J Med Chem       Date:  2011-03-09       Impact factor: 7.446

6.  Physicochemical properties and membrane interactions of anti-apoptotic derivatives 2-(4-fluorophenyl)-3-(pyridin-4-yl)imidazo[1,2-a]pyridine depending on the hydroxyalkylamino side chain length and conformation: an NMR and ESR study.

Authors:  Sébastien Follot; Jean-Claude Debouzy; David Crouzier; Cécile Enguehard-Gueiffier; Alain Gueiffier; Florian Nachon; Bertrand Lefebvre; Florence Fauvelle
Journal:  Eur J Med Chem       Date:  2009-01-10       Impact factor: 6.514

7.  Synthesis and antiprotozoal activity of novel bis-benzamidino imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines.

Authors:  Mohamed A Ismail; Reem K Arafa; Tanja Wenzler; Reto Brun; Farial A Tanious; W David Wilson; David W Boykin
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

8.  The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor.

Authors:  Kate F Byth; Catherine Geh; Cheryl L Forder; Sandra E Oakes; Andrew P Thomas
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

9.  Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.

Authors:  Steven L Colletti; Jessica L Frie; Elizabeth C Dixon; Suresh B Singh; Bernard K Choi; Giovanna Scapin; Catherine E Fitzgerald; Sanjeev Kumar; Elizabeth A Nichols; Stephen J O'Keefe; Edward A O'Neill; Gene Porter; Koppara Samuel; Dennis M Schmatz; Cheryl D Schwartz; Wesley L Shoop; Chris M Thompson; James E Thompson; Ruixiu Wang; Andrea Woods; Dennis M Zaller; James B Doherty
Journal:  J Med Chem       Date:  2003-01-30       Impact factor: 7.446

10.  3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors.

Authors:  Cécile Enguehard-Gueiffier; Simone Musiu; Nicolas Henry; Jean-Baptiste Véron; Sylvie Mavel; Johan Neyts; Pieter Leyssen; Jan Paeshuyse; Alain Gueiffier
Journal:  Eur J Med Chem       Date:  2013-04-19       Impact factor: 6.514

View more
  4 in total

1.  Metal-free, efficient hydrazination of imidazo[1,2-a]pyridine with diethyl azodicarboxylate in neutral media.

Authors:  Yuanxiang Wang; Brendan Frett; Nick McConnell; Hong-Yu Li
Journal:  Org Biomol Chem       Date:  2015-03-14       Impact factor: 3.876

2.  Computer aided drug discovery of highly ligand efficient, low molecular weight imidazopyridine analogs as FLT3 inhibitors.

Authors:  Brendan Frett; Nick McConnell; Catherine C Smith; Yuanxiang Wang; Neil P Shah; Hong-yu Li
Journal:  Eur J Med Chem       Date:  2015-02-28       Impact factor: 6.514

3.  Selective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-a]pyridine derivatives.

Authors:  Brendan Frett; Nicholas McConnell; Anupreet Kharbanda; Gunaganti Naresh; Benjamin Rounseville; Christina Warner; John Chang; Natalie Debolske; Hong-Yu Li
Journal:  Tetrahedron       Date:  2018-07-17       Impact factor: 2.457

4.  Metal-free C-H arylation of imidazoheterocycles with aryl hydrazines.

Authors:  Sourav Jana; Sadhanendu Samanta; Avik K Bagdi; Valerii Z Shirinian; Alakananda Hajra
Journal:  RSC Adv       Date:  2018-04-03       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.